TreeWAS
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs7715811
log Bayes Factor = 2.69078
Chromosome 5   position 13,769,974  (GRCh37) Explore rs7715811 on Ensembl!
Variant rs7715811 is listed in the   GWAS Catalog  

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
No effect
posterior probability
Protective
posterior probability
 
T36-T50 Poisoning by drugs, medicaments and biological substances
0.997 0.003 0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs
0.993 0.007 0.000
T46 Poisoning by agents primarily affecting the cardiovascular system
0.991 0.009 0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances
0.973 0.027 0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs
0.971 0.029 0.000
T50.9 Other and unspecified drugs, medicaments and biological substances
0.944 0.056 0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.944 0.056 0.000
T46.1 Calcium-channel blockers
0.943 0.057 0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified
0.921 0.079 0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system
0.916 0.084 0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.911 0.089 0.000
T42.4 Benzodiazepines
0.903 0.097 0.000
T43.2 Other and unspecified antidepressants
0.901 0.099 0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system
0.901 0.099 0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.889 0.111 0.000
T46.4 Angiotensin-converting-enzyme inhibitors
0.848 0.152 0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified
0.825 0.175 0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified
0.815 0.185 0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified
0.813 0.187 0.000
T47.1 Other antacids and anti-gastric-secretion drugs
0.786 0.214 0.000
T50.1 Loop [high-ceiling] diuretics
0.778 0.222 0.000
T38.8 Other and unspecified hormones and their synthetic substitutes
0.762 0.238 0.000
T42.0 Hydantoin derivatives
0.762 0.238 0.000
T43.5 Other and unspecified antipsychotics and neuroleptics
0.759 0.241 0.000
T42.1 Iminostilbenes
0.756 0.244 0.000
T50.4 Drugs affecting uric acid metabolism
0.751 0.249 0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
0.749 0.251 0.000
T36 Poisoning by systemic antibiotics
0.744 0.256 0.000
T50.6 Antidotes and chelating agents, not elsewhere classified
0.742 0.258 0.000
T47.2 Stimulant laxatives
0.737 0.263 0.000
T46.3 Coronary vasodilators, not elsewhere classified
0.722 0.278 0.000
T47.4 Other laxatives
0.717 0.283 0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs
0.715 0.285 0.000
T41 Poisoning by anaesthetics and therapeutic gases
0.715 0.285 0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]
0.713 0.287 0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants
0.712 0.288 0.000
T42.5 Mixed antiepileptics, not elsewhere classified
0.712 0.288 0.000
T42.3 Barbiturates
0.712 0.288 0.000
T42.2 Succinimides and oxazolidinediones
0.712 0.288 0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics
0.712 0.288 0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system
0.710 0.290 0.000
T46.8 Antivaricose drugs, including sclerosing agents
0.710 0.290 0.000
T46.7 Peripheral vasodilators
0.710 0.290 0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action
0.710 0.290 0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system
0.701 0.298 0.000
T50.7 Analeptics and opioid receptor antagonists
0.698 0.302 0.000
T50.5 Appetite depressants
0.698 0.302 0.000
T50.3 Electrolytic, caloric and water-balance agents
0.698 0.302 0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
0.698 0.302 0.000
T50.0 Mineralocorticoids and their antagonists
0.698 0.302 0.000
T47.6 Antidiarrhoeal drugs
0.695 0.304 0.000
T38.9 Other and unspecified hormone antagonists
0.677 0.323 0.000
T38.7 Androgens and anabolic congeners
0.677 0.323 0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified
0.677 0.323 0.000
T38.5 Other oestrogens and progestogens
0.677 0.323 0.000
T38.4 Oral contraceptives
0.677 0.323 0.000
T38.2 Antithyroid drugs
0.677 0.323 0.000
T38.0 Glucocorticoids and synthetic analogues
0.677 0.323 0.000
T46.5 Other antihypertensive drugs, not elsewhere classified
0.670 0.330 0.000
T38.1 Thyroid hormones and substitutes
0.668 0.332 0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants
0.666 0.334 0.000
T43.9 Psychotropic drug, unspecified
0.660 0.339 0.000
T43.8 Other psychotropic drugs, not elsewhere classified
0.660 0.339 0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.656 0.343 0.000
T47.8 Other agents primarily affecting the gastro-intestinal system
0.656 0.343 0.000
T47.7 Emetics
0.656 0.343 0.000
T47.5 Digestants
0.656 0.343 0.000
T47.3 Saline and osmotic laxatives
0.656 0.343 0.000
T47.0 Histamine H(2)-receptor antagonists
0.656 0.343 0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified
0.646 0.354 0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified
0.646 0.354 0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.646 0.354 0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.646 0.354 0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified
0.646 0.354 0.000
T44.1 Other parasympathomimetics [cholinergics]
0.646 0.354 0.000
T44.0 Anticholinesterase agents
0.646 0.354 0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified
0.645 0.355 0.000
T50.8 Diagnostic agents
0.640 0.360 0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified
0.605 0.395 0.000
T43.3 Phenothiazine antipsychotics and neuroleptics
0.602 0.398 0.000
T43.4 Butyrophenone and thioxanthene neuroleptics
0.578 0.422 0.000
T48.6 Antiasthmatics, not elsewhere classified
0.572 0.428 0.000
T40.3 Methadone
0.570 0.430 0.000
T43.6 Psychostimulants with abuse potential
0.569 0.431 0.000
T36.0 Penicillins
0.562 0.438 0.000
T40.2 Other opioids
0.550 0.450 0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system
0.537 0.463 0.000
T48.5 Anti-common-cold drugs
0.537 0.463 0.000
T48.4 Expectorants
0.537 0.463 0.000
T48.3 Antitussives
0.537 0.463 0.000
T48.2 Other and unspecified agents primarily acting on muscles
0.537 0.463 0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.537 0.463 0.000
T48.0 Oxytocic drugs
0.537 0.463 0.000
T36.9 Systemic antibiotic, unspecified
0.533 0.466 0.000
T36.8 Other systemic antibiotics
0.533 0.466 0.000
T36.7 Antifungal antibiotics, systemically used
0.533 0.466 0.000
T36.6 Rifamycins
0.533 0.466 0.000
T36.5 Aminoglycosides
0.533 0.466 0.000
T36.4 Tetracyclines
0.533 0.466 0.000
T36.3 Macrolides
0.533 0.466 0.000
T36.2 Chloramphenicol group
0.533 0.466 0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics
0.533 0.466 0.000
T41.5 Therapeutic gases
0.513 0.487 0.000
T41.4 Anaesthetic, unspecified
0.513 0.487 0.000
T41.3 Local anaesthetics
0.513 0.487 0.000
T41.2 Other and unspecified general anaesthetics
0.513 0.487 0.000
T41.1 Intravenous anaesthetics
0.513 0.487 0.000
T41.0 Inhaled anaesthetics
0.513 0.487 0.000
T49.9 Topical agent, unspecified
0.513 0.487 0.000
T49.8 Other topical agents
0.513 0.487 0.000
T49.7 Dental drugs, topically applied
0.513 0.487 0.000
T49.6 Otorhinolaryngological drugs and preparations
0.513 0.487 0.000
T49.5 Ophthalmological drugs and preparations
0.513 0.487 0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.513 0.487 0.000
T49.3 Emollients, demulcents and protectants
0.513 0.487 0.000
T49.2 Local astringents and local detergents
0.513 0.487 0.000
T49.1 Antipruritics
0.513 0.487 0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.513 0.487 0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]
0.511 0.489 0.000
T40.8 Lysergide [LSD]
0.511 0.489 0.000
T40.7 Cannabis (derivatives)
0.511 0.489 0.000
T40.5 Cocaine
0.511 0.489 0.000
T40.1 Heroin
0.511 0.489 0.000
T40.0 Opium
0.511 0.489 0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified
0.510 0.489 0.000
T37.5 Antiviral drugs
0.510 0.489 0.000
T37.4 Anthelminthics
0.510 0.489 0.000
T37.3 Other antiprotozoal drugs
0.510 0.489 0.000
T37.2 Antimalarials and drugs acting on other blood protozoa
0.510 0.489 0.000
T37.1 Antimycobacterial drugs
0.510 0.489 0.000
T37.0 Sulphonamides
0.510 0.489 0.000
T37.8 Other specified systemic anti-infectives and antiparasitics
0.507 0.492 0.000
T45.5 Anticoagulants
0.484 0.516 0.000
T40.6 Other and unspecified narcotics
0.481 0.518 0.000
T45.9 Primarily systemic and haematological agent, unspecified
0.463 0.537 0.000
T45.8 Other primarily systemic and haematological agents
0.463 0.537 0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants
0.463 0.537 0.000
T45.6 Fibrinolysis-affecting drugs
0.463 0.537 0.000
T45.4 Iron and its compounds
0.463 0.537 0.000
T45.3 Enzymes, not elsewhere classified
0.463 0.537 0.000
T45.0 Antiallergic and antiemetic drugs
0.447 0.553 0.000
T45.1 Antineoplastic and immunosuppressive drugs
0.435 0.564 0.000
T45.2 Vitamins, not elsewhere classified
0.417 0.583 0.000
T40.4 Other synthetic narcotics
0.402 0.598 0.000
T43.0 Tricyclic and tetracyclic antidepressants
0.398 0.602 0.000
C18.0 Caecum
0.298 0.702 0.000
C18 Malignant neoplasm of colon
0.290 0.710 0.000
C15-C26 Malignant neoplasms of digestive organs
0.290 0.710 0.000
C19 Malignant neoplasm of rectosigmoid junction
0.287 0.713 0.000
C16 Malignant neoplasm of stomach
0.285 0.715 0.000
C18.1 Appendix
0.273 0.727 0.000
C16.0 Cardia
0.266 0.734 0.000
C25 Malignant neoplasm of pancreas
0.263 0.737 0.000
C24 Malignant neoplasm of other and unspecified parts of biliary tract
0.257 0.743 0.000
C18.3 Hepatic flexure
0.257 0.743 0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics
0.256 0.744 0.000
C16.9 Stomach, unspecified
0.252 0.748 0.000
C16.3 Pyloric antrum
0.251 0.749 0.000
C25.9 Pancreas, unspecified
0.242 0.758 0.000
C24.1 Ampulla of Vater
0.226 0.774 0.000
C25.0 Head of pancreas
0.224 0.776 0.000
C17 Malignant neoplasm of small intestine
0.218 0.782 0.000
C18.9 Colon, unspecified
0.213 0.787 0.000
C16.5 Lesser curvature of stomach, unspecified
0.212 0.788 0.000
C16.2 Body of stomach
0.210 0.790 0.000
C25.3 Pancreatic duct
0.207 0.793 0.000
C16.8 Overlapping lesion of stomach
0.205 0.795 0.000
C21 Malignant neoplasm of anus and anal canal
0.204 0.796 0.000
C18.5 Splenic flexure
0.200 0.800 0.000
C24.0 Extrahepatic bile duct
0.200 0.800 0.000
C20 Malignant neoplasm of rectum
0.194 0.806 0.000
C17.9 Small intestine, unspecified
0.193 0.807 0.000
C16.4 Pylorus
0.192 0.808 0.000
C16.1 Fundus of stomach
0.191 0.809 0.000
C16.6 Greater curvature of stomach, unspecified
0.191 0.809 0.000
T39.1 4-Aminophenol derivatives
0.191 0.809 0.000
C24.9 Biliary tract, unspecified
0.189 0.811 0.000
C18.2 Ascending colon
0.189 0.811 0.000
C25.8 Overlapping lesion of pancreas
0.188 0.811 0.000
C25.7 Other parts of pancreas
0.188 0.811 0.000
C25.4 Endocrine pancreas
0.188 0.811 0.000
C24.8 Overlapping lesion of biliary tract
0.185 0.815 0.000
C26 Malignant neoplasm of other and ill-defined digestive organs
0.184 0.816 0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified
0.184 0.816 0.000
T39.4 Antirheumatics, not elsewhere classified
0.183 0.817 0.000
T39.2 Pyrazolone derivatives
0.183 0.817 0.000
C18.8 Overlapping lesion of colon
0.176 0.824 0.000
C23 Malignant neoplasm of gallbladder
0.172 0.828 0.000
C21.0 Anus, unspecified
0.167 0.833 0.000
C17.2 Ileum
0.162 0.838 0.000
C25.1 Body of pancreas
0.159 0.840 0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified
0.159 0.841 0.000
C17.8 Overlapping lesion of small intestine
0.157 0.843 0.000
C17.3 Meckel's diverticulum
0.157 0.843 0.000
C26.9 Ill-defined sites within the digestive system
0.148 0.851 0.000
C21.2 Cloacogenic zone
0.147 0.853 0.000
C21.8 Overlapping lesion of rectum, anus and anal canal
0.137 0.863 0.000
C25.2 Tail of pancreas
0.135 0.864 0.000
C26.8 Overlapping lesion of digestive system
0.132 0.867 0.000
C26.1 Spleen
0.132 0.867 0.000
C17.1 Jejunum
0.131 0.868 0.000
C77.2 Intra-abdominal lymph nodes
0.125 0.875 0.000
C21.1 Anal canal
0.122 0.878 0.000
C17.0 Duodenum
0.121 0.879 0.000
C77 Secondary and unspecified malignant neoplasm of lymph nodes
0.120 0.880 0.000
C77.9 Lymph node, unspecified
0.118 0.882 0.000
C78 Secondary malignant neoplasm of respiratory and digestive organs
0.118 0.882 0.000
C18.4 Transverse colon
0.117 0.883 0.000
C76-C80 Malignant neoplasms of ill-defined, secondary and unspecified sites
0.116 0.884 0.000
C78.7 Secondary malignant neoplasm of liver
0.112 0.888 0.000
C78.2 Secondary malignant neoplasm of pleura
0.112 0.888 0.000
C18.6 Descending colon
0.110 0.889 0.000
C78.0 Secondary malignant neoplasm of lung
0.100 0.900 0.000
C18.7 Sigmoid colon
0.099 0.901 0.000
C77.4 Inguinal and lower limb lymph nodes
0.096 0.904 0.000
C80 Malignant neoplasm without specification of site
0.096 0.904 0.000
C78.5 Secondary malignant neoplasm of large intestine and rectum
0.095 0.905 0.000
C78.8 Secondary malignant neoplasm of other and unspecified digestive organs
0.091 0.909 0.000
C79 Secondary malignant neoplasm of other sites
0.090 0.910 0.000
C22 Malignant neoplasm of liver and intrahepatic bile ducts
0.088 0.912 0.000
C79.1 Secondary malignant neoplasm of bladder and other and unspecified urinary organs
0.084 0.916 0.000
C78.3 Secondary malignant neoplasm of other and unspecified respiratory organs
0.083 0.917 0.000
C77.5 Intrapelvic lymph nodes
0.082 0.918 0.000
C80.0 Malignant neoplasm, primary site unknown, so stated
0.081 0.919 0.000
C79.3 Secondary malignant neoplasm of brain and cerebral meninges
0.079 0.921 0.000
C79.6 Secondary malignant neoplasm of ovary
0.078 0.922 0.000
C15 Malignant neoplasm of oesophagus
0.077 0.923 0.000
T39.0 Salicylates
0.076 0.924 0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]
0.076 0.924 0.000
C77.8 Lymph nodes of multiple regions
0.076 0.924 0.000
C79.2 Secondary malignant neoplasm of skin
0.075 0.925 0.000
C26.0 Intestinal tract, part unspecified
0.075 0.925 0.000
C76 Malignant neoplasm of other and ill-defined sites
0.074 0.926 0.000
C78.1 Secondary malignant neoplasm of mediastinum
0.073 0.927 0.000
C80.9 Malignant neoplasm, unspecified
0.069 0.930 0.000
C77.3 Axillary and upper limb lymph nodes
0.069 0.931 0.000
C78.4 Secondary malignant neoplasm of small intestine
0.069 0.931 0.000
C22.7 Other specified carcinomas of liver
0.063 0.937 0.000
C22.4 Other sarcomas of liver
0.063 0.937 0.000
C22.3 Angiosarcoma of liver
0.063 0.937 0.000
C22.2 Hepatoblastoma
0.063 0.937 0.000
C79.5 Secondary malignant neoplasm of bone and bone marrow
0.062 0.938 0.000
C76.3 Pelvis
0.061 0.939 0.000
C78.6 Secondary malignant neoplasm of retroperitoneum and peritoneum
0.060 0.940 0.000
C76.1 Thorax
0.057 0.943 0.000
C15.4 Middle third of oesophagus
0.056 0.944 0.000
C15.8 Overlapping lesion of oesophagus
0.055 0.944 0.000
C15.2 Abdominal part of oesophagus
0.055 0.944 0.000
C15.1 Thoracic part of oesophagus
0.055 0.944 0.000
C15.0 Cervical part of oesophagus
0.055 0.944 0.000
C79.0 Secondary malignant neoplasm of kidney and renal pelvis
0.054 0.946 0.000
C76.8 Overlapping lesion of other and ill-defined sites
0.053 0.947 0.000
C76.7 Other ill-defined sites
0.053 0.947 0.000
C76.5 Lower limb
0.053 0.947 0.000
C76.4 Upper limb
0.053 0.947 0.000
C79.4 Secondary malignant neoplasm of other and unspecified parts of nervous system
0.050 0.950 0.000
D69.6 Thrombocytopenia, unspecified
0.049 0.951 0.000
C77.0 Lymph nodes of head, face and neck
0.049 0.951 0.000
C22.9 Liver, unspecified
0.047 0.953 0.000
C76.2 Abdomen
0.047 0.953 0.000
C15.3 Upper third of oesophagus
0.047 0.953 0.000
C22.1 Intrahepatic bile duct carcinoma
0.046 0.954 0.000
C79.9 Secondary malignant neoplasm, unspecified site
0.042 0.958 0.000
D69 Purpura and other haemorrhagic conditions
0.038 0.962 0.000
C22.0 Liver cell carcinoma
0.035 0.964 0.000
C77.1 Intrathoracic lymph nodes
0.035 0.965 0.000
D69.5 Secondary thrombocytopenia
0.034 0.966 0.000
C79.8 Secondary malignant neoplasm of other specified sites
0.034 0.966 0.000
C15.9 Oesophagus, unspecified
0.033 0.967 0.000
D69.3 Idiopathic thrombocytopenic purpura
0.033 0.967 0.000
C79.7 Secondary malignant neoplasm of adrenal gland
0.031 0.969 0.000
C76.0 Head, face and neck
0.028 0.971 0.001
D69.2 Other nonthrombocytopenic purpura
0.028 0.972 0.000
D69.8 Other specified haemorrhagic conditions
0.027 0.972 0.000
D69.1 Qualitative platelet defects
0.027 0.972 0.000
D69.0 Allergic purpura
0.026 0.974 0.000
D69.4 Other primary thrombocytopenia
0.026 0.974 0.000
D65-D69 Coagulation defects, purpura and other haemorrhagic conditions
0.024 0.976 0.000
C15.5 Lower third of oesophagus
0.020 0.980 0.000
D66 Hereditary factor VIII deficiency
0.020 0.980 0.000
D65 Disseminated intravascular coagulation [defibrination syndrome]
0.020 0.980 0.000
D67 Hereditary factor IX deficiency
0.019 0.981 0.000
D69.9 Haemorrhagic condition, unspecified
0.017 0.983 0.000
Chapter II Neoplasms
0.015 0.985 0.000
I82.9 Embolism and thrombosis of unspecified vein
0.015 0.985 0.000
D23.4 Skin of scalp and neck
0.015 0.985 0.000
C69-C72 Malignant neoplasms of eye, brain and other parts of central nervous system
0.015 0.985 0.000
C45-C49 Malignant neoplasms of mesothelial and soft tissue
0.014 0.986 0.000
C71 Malignant neoplasm of brain
0.014 0.986 0.000
I82.2 Embolism and thrombosis of vena cava
0.014 0.986 0.000
C71.2 Temporal lobe
0.014 0.986 0.000
I82 Other venous embolism and thrombosis
0.014 0.986 0.000
D44 Neoplasm of uncertain or unknown behaviour of endocrine glands
0.014 0.986 0.000
C71.1 Frontal lobe
0.013 0.987 0.000
D68 Other coagulation defects
0.013 0.987 0.000
D37-D48 Neoplasms of uncertain or unknown behaviour
0.012 0.988 0.000
C48 Malignant neoplasm of retroperitoneum and peritoneum
0.012 0.988 0.000
I82.0 Budd-Chiari syndrome
0.012 0.988 0.000
C49 Malignant neoplasm of other connective and soft tissue
0.012 0.988 0.000
D44.3 Pituitary gland
0.012 0.988 0.000
C45 Mesothelioma
0.012 0.988 0.000
C48.2 Peritoneum, unspecified
0.011 0.989 0.000
D44.8 Pluriglandular involvement
0.011 0.989 0.000
M25.71 Osteophyte (Shoulder region)
0.011 0.989 0.000
I82.3 Embolism and thrombosis of renal vein
0.011 0.989 0.000
D44.4 Craniopharyngeal duct
0.011 0.989 0.000
D44.0 Thyroid gland
0.011 0.989 0.000
C71.6 Cerebellum
0.011 0.989 0.000
C72 Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system
0.011 0.989 0.000
D44.6 Carotid body
0.011 0.989 0.000
D44.7 Aortic body and other paraganglia
0.011 0.989 0.000
C70 Malignant neoplasm of meninges
0.011 0.989 0.000
C71.8 Overlapping lesion of brain
0.011 0.989 0.000
C71.7 Brain stem
0.010 0.989 0.000
C47 Malignant neoplasm of peripheral nerves and autonomic nervous system
0.010 0.989 0.000
C46 Kaposi's sarcoma
0.010 0.989 0.000
C49.9 Connective and soft tissue, unspecified
0.010 0.989 0.000
D44.9 Endocrine gland, unspecified
0.010 0.989 0.000
D68.1 Hereditary factor XI deficiency
0.010 0.990 0.000
C71.5 Cerebral ventricle
0.010 0.990 0.000
D44.1 Adrenal gland
0.010 0.990 0.000
C69 Malignant neoplasm of eye and adnexa
0.010 0.990 0.000
D43 Neoplasm of uncertain or unknown behaviour of brain and central nervous system
0.010 0.990 0.000
C49.2 Connective and soft tissue of lower limb, including hip
0.010 0.990 0.000
D68.4 Acquired coagulation factor deficiency
0.010 0.990 0.000
I82.1 Thrombophlebitis migrans
0.010 0.990 0.000
D39 Neoplasm of uncertain or unknown behaviour of female genital organs
0.010 0.990 0.000
C71.9 Brain, unspecified
0.010 0.990 0.000
D44.5 Pineal gland
0.010 0.990 0.000
D44.2 Parathyroid gland
0.010 0.990 0.000
I82.8 Embolism and thrombosis of other specified veins
0.010 0.990 0.000
C71.4 Occipital lobe
0.010 0.990 0.000
C71.0 Cerebrum, except lobes and ventricles
0.010 0.990 0.000
D37 Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs
0.010 0.990 0.000
D43.4 Spinal cord
0.010 0.990 0.000
C49.3 Connective and soft tissue of thorax
0.009 0.990 0.000
C49.6 Connective and soft tissue of trunk, unspecified
0.009 0.990 0.000
D38 Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs
0.009 0.991 0.000
C48.0 Retroperitoneum
0.009 0.991 0.000
D68.6 Other Thrombophilia
0.009 0.991 0.000
C45.7 Mesothelioma of other sites
0.009 0.991 0.000
C45.0 Mesothelioma of pleura
0.009 0.991 0.000
D68.3 Haemorrhagic disorder due to circulating anticoagulants
0.009 0.991 0.000
C40-C41 Malignant neoplasms of bone and articular cartilage
0.009 0.991 0.000
D42 Neoplasm of uncertain or unknown behaviour of meninges
0.009 0.991 0.000
C48.8 Overlapping lesion of retroperitoneum and peritoneum
0.009 0.991 0.000
D68.8 Other specified coagulation defects
0.009 0.991 0.000
C49.8 Overlapping lesion of connective and soft tissue
0.009 0.991 0.000
D68.0 Von Willebrand's disease
0.009 0.991 0.000
C69.6 Orbit
0.009 0.991 0.000
D39.7 Other female genital organs
0.009 0.991 0.000
C49.4 Connective and soft tissue of abdomen
0.009 0.991 0.000
G91.9 Hydrocephalus, unspecified
0.009 0.991 0.000
C73-C75 Malignant neoplasms of thyroid and other endocrine glands
0.009 0.991 0.000
C45.2 Mesothelioma of pericardium
0.008 0.991 0.000
C45.1 Mesothelioma of peritoneum
0.008 0.991 0.000
D43.0 Brain, supratentorial
0.009 0.991 0.000
D37.6 Liver, gallbladder and bile ducts
0.008 0.991 0.000
C45.9 Mesothelioma, unspecified
0.008 0.992 0.000
C49.1 Connective and soft tissue of upper limb, including shoulder
0.008 0.992 0.000
D37.0 Lip, oral cavity and pharynx
0.008 0.992 0.000
C72.0 Spinal cord
0.008 0.992 0.000
C97-C97 Malignant neoplasms of independent (primary) multiple sites
0.008 0.992 0.000
D48 Neoplasm of uncertain or unknown behaviour of other and unspecified sites
0.008 0.992 0.000
D37.4 Colon
0.008 0.992 0.000
C49.5 Connective and soft tissue of pelvis
0.008 0.992 0.000
C70.0 Cerebral meninges
0.008 0.992 0.000
C72.9 Central nervous system, unspecified
0.008 0.992 0.000
C72.8 Overlapping lesion of brain and other parts of central nervous system
0.008 0.992 0.000
C72.5 Other and unspecified cranial nerves
0.008 0.992 0.000
C72.4 Acoustic nerve
0.008 0.992 0.000
C72.3 Optic nerve
0.008 0.992 0.000
C72.2 Olfactory nerve
0.008 0.992 0.000
C72.1 Cauda equina
0.008 0.992 0.000
C70.9 Meninges, unspecified
0.008 0.992 0.000
C70.1 Spinal meninges
0.008 0.992 0.000
D40 Neoplasm of uncertain or unknown behaviour of male genital organs
0.008 0.992 0.000
C69.9 Eye, unspecified
0.008 0.992 0.000
C69.2 Retina
0.008 0.992 0.000
D37.2 Small intestine
0.008 0.992 0.000
C46.9 Kaposi's sarcoma, unspecified
0.008 0.992 0.000
C46.8 Kaposi's sarcoma of multiple organs
0.008 0.992 0.000
C46.7 Kaposi's sarcoma of other sites
0.008 0.992 0.000
C46.3 Kaposi's sarcoma of lymph nodes
0.008 0.992 0.000
C46.2 Kaposi's sarcoma of palate
0.008 0.992 0.000
C46.1 Kaposi's sarcoma of soft tissue
0.008 0.992 0.000
C46.0 Kaposi's sarcoma of skin
0.008 0.992 0.000
C47.9 Peripheral nerves and autonomic nervous system, unspecified
0.008 0.992 0.000
C47.8 Overlapping lesion of peripheral nerves and autonomic nervous system
0.008 0.992 0.000
C47.6 Peripheral nerves of trunk, unspecified
0.008 0.992 0.000
C47.5 Peripheral nerves of pelvis
0.008 0.992 0.000
C47.4 Peripheral nerves of abdomen
0.008 0.992 0.000
C47.3 Peripheral nerves of thorax
0.008 0.992 0.000
C47.2 Peripheral nerves of lower limb, including hip
0.008 0.992 0.000
C47.1 Peripheral nerves of upper limb, including shoulder
0.008 0.992 0.000
C47.0 Peripheral nerves of head, face and neck
0.008 0.992 0.000
D68.9 Coagulation defect, unspecified
0.008 0.992 0.000
D48.6 Breast
0.008 0.992 0.000
D38.5 Other respiratory organs
0.008 0.992 0.000
C69.8 Overlapping lesion of eye and adnexa
0.007 0.992 0.000
C69.5 Lachrymal gland and duct
0.007 0.992 0.000
C69.4 Ciliary body
0.007 0.992 0.000
C69.1 Cornea
0.007 0.992 0.000
D37.3 Appendix
0.008 0.992 0.000
D43.9 Central nervous system, unspecified
0.007 0.992 0.000
D43.7 Other parts of central nervous system
0.007 0.992 0.000
D43.3 Cranial nerves
0.007 0.992 0.000
D39.9 Female genital organ, unspecified
0.007 0.992 0.000
D39.2 Placenta
0.007 0.992 0.000
D37.1 Stomach
0.007 0.993 0.000
D39.1 Ovary
0.007 0.993 0.000
C48.1 Specified parts of peritoneum
0.007 0.993 0.000
M79.79 Fibromyalgia (Site unspecified)
0.000 0.993 0.007
D68.2 Hereditary deficiency of other clotting factors
0.007 0.993 0.000
C71.3 Parietal lobe
0.007 0.993 0.000
D68.5 Primary Thrombophilia
0.007 0.993 0.000
D39.0 Uterus
0.007 0.993 0.000
D38.6 Respiratory organ, unspecified
0.007 0.993 0.000
D38.4 Thymus
0.007 0.993 0.000
D38.3 Mediastinum
0.007 0.993 0.000
D38.2 Pleura
0.007 0.993 0.000
M79.70 Fibromyalgia (Multiple sites)
0.000 0.993 0.007
D38.0 Larynx
0.007 0.993 0.000
D47 Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue
0.007 0.993 0.000
C69.0 Conjunctiva
0.007 0.993 0.000
C42 hematopoietic and reticuloendothelial systems (ICD-O-3 specific)
0.007 0.993 0.000
D42.9 Meninges, unspecified
0.007 0.993 0.000
D42.1 Spinal meninges
0.007 0.993 0.000
D42.0 Cerebral meninges
0.007 0.993 0.000
C75 Malignant neoplasm of other endocrine glands and related structures
0.007 0.993 0.000
D38.1 Trachea, bronchus and lung
0.007 0.993 0.000
D48.0 Bone and articular cartilage
0.007 0.993 0.000
C49.0 Connective and soft tissue of head, face and neck
0.006 0.993 0.000
D43.1 Brain, infratentorial
0.006 0.993 0.000
C50-C50 Malignant neoplasm of breast
0.006 0.993 0.000
D48.4 Peritoneum
0.006 0.993 0.000
D48.2 Peripheral nerves and autonomic nervous system
0.006 0.994 0.000
C40 Malignant neoplasm of bone and articular cartilage of limbs
0.006 0.994 0.000
D48.3 Retroperitoneum
0.006 0.994 0.000
N99.3 Prolapse of vaginal vault after hysterectomy
0.000 0.994 0.006
D48.9 Neoplasms of uncertain or unknown behaviour, unspecified
0.006 0.994 0.000
M79.7 Fibromyalgia
0.000 0.994 0.006
D46 Myelodysplastic syndromes
0.006 0.994 0.000
D40.9 Male genital organ, unspecified
0.006 0.994 0.000
D40.7 Other male genital organs
0.006 0.994 0.000
C74 Malignant neoplasm of adrenal gland
0.006 0.994 0.000
D40.0 Prostate
0.006 0.994 0.000
M46.92 Inflammatory spondylopathy, unspecified (Cervical region)
0.000 0.994 0.006
D37.7 Other digestive organs
0.006 0.994 0.000
D37.9 Digestive organ, unspecified
0.006 0.994 0.000
D41 Neoplasm of uncertain or unknown behaviour of urinary organs
0.006 0.994 0.000
C00-C14 Malignant neoplasms of lip, oral cavity and pharynx
0.006 0.994 0.000
D43.2 Brain, unspecified
0.006 0.994 0.000
D47.4 Osteomyelofibrosis
0.006 0.994 0.000
D47.9 Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified
0.005 0.994 0.000
D48.7 Other specified sites
0.005 0.994 0.000
C69.3 Choroid
0.005 0.995 0.000
C64-C68 Malignant neoplasms of urinary tract
0.005 0.995 0.000
D47.7 Other specified neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue
0.005 0.995 0.000
C75.9 Endocrine gland, unspecified
0.005 0.995 0.000
C41 Malignant neoplasm of bone and articular cartilage of other and unspecified sites
0.005 0.995 0.000
K11.5 Sialolithiasis
0.005 0.995 0.000
R82.8 Abnormal findings on cytological and histological examination of urine
0.005 0.995 0.000
D47.5 Chronic eosinophilic leukaemia [hypereosinophilic syndrome]
0.005 0.995 0.000
D47.0 Histiocytic and mast cell tumours of uncertain and unknown behaviour
0.005 0.995 0.000
C42.4 hematopoietic and reticuloendothelial systems: Hematopoietic system, NOS (ICD-O-3 specific)
0.005 0.995 0.000
C42.3 hematopoietic and reticuloendothelial systems: Reticuloendothelial system, NOS (ICD-O-3 specific)
0.005 0.995 0.000
C42.2 hematopoietic and reticuloendothelial systems: spleen (ICD-O-3 specific)
0.005 0.995 0.000
C42.1 hematopoietic and reticuloendothelial systems: bone marrow (ICD-O-3 specific)
0.005 0.995 0.000
C42.0 hematopoietic and reticuloendothelial systems: blood (ICD-O-3 specific)
0.005 0.995 0.000
D48.1 Connective and other soft tissue
0.005 0.995 0.000
C75.8 Pluriglandular involvement, unspecified
0.005 0.995 0.000
C75.5 Aortic body and other paraganglia
0.005 0.995 0.000
C75.4 Carotid body
0.005 0.995 0.000
C75.3 Pineal gland
0.005 0.995 0.000
C75.2 Craniopharyngeal duct
0.005 0.995 0.000
C75.1 Pituitary gland
0.005 0.995 0.000
C75.0 Parathyroid gland
0.005 0.995 0.000
C04 Malignant neoplasm of floor of mouth
0.005 0.995 0.000
D40.1 Testis
0.005 0.995 0.000
D47.2 Monoclonal gammopathy
0.005 0.995 0.000
M23.20 Derangement of meniscus due to old tear or injury (Multiple sites)
0.005 0.995 0.000
D46.7 Other myelodysplastic syndromes
0.005 0.995 0.000
C40.9 Bone and articular cartilage of limb, unspecified
0.004 0.995 0.000
C40.8 Overlapping lesion of bone and articular cartilage of limbs
0.004 0.995 0.000
C40.3 Short bones of lower limb
0.004 0.995 0.000
C40.1 Short bones of upper limb
0.004 0.995 0.000
C40.0 Scapula and long bones of upper limb
0.004 0.995 0.000
D41.1 Renal pelvis
0.005 0.995 0.000
C07 Malignant neoplasm of parotid gland
0.005 0.995 0.000
D45 Polycythaemia vera
0.005 0.995 0.000
C04.9 Floor of mouth, unspecified
0.005 0.995 0.000
C51-C58 Malignant neoplasms of female genital organs
0.005 0.995 0.000
C13 Malignant neoplasm of hypopharynx
0.005 0.995 0.000
C74.1 Medulla of adrenal gland
0.004 0.995 0.000
M79.78 Fibromyalgia (Other)
0.000 0.995 0.005
M79.77 Fibromyalgia (Ankle and foot)
0.000 0.995 0.005
M79.76 Fibromyalgia (Lower leg)
0.000 0.995 0.005
M79.75 Fibromyalgia (Pelvic region and thigh)
0.000 0.995 0.005
M79.74 Fibromyalgia (Hand)
0.000 0.995 0.005

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.